<DOC>
	<DOCNO>NCT00931372</DOCNO>
	<brief_summary>The objective study test whether Lixisenatide ( AVE0010 ) restore first phase improve second phase insulin response subject diabetes mellitus type 2 .</brief_summary>
	<brief_title>Lixisenatide Restoration Insulin Release Subjects With Diabetes Mellitus Type 2</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Male female subject type 2 diabetes mellitus diet exercise with/without metformin HbA1c &gt; =6,0 % &lt; =8,5 % screen BMI 25 35 kg/mÂ² 155 &gt; =BP systolic &gt; =90 mmHg 100 &gt; =BP diastolic &gt; =45 mmHg The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Insulin release</keyword>
	<keyword>Diabetes mellitus type 2</keyword>
	<keyword>GLP-1 agonist</keyword>
</DOC>